Sign in

iiinova is part of the Atmosphere — an open, public network where you own your identity.

Nature Reviews Gastroenterology & Hepatology

@natrevgastrohep.nature.com
5.2K followers 1.3K following 1.1K posts

We publish #gastroenterology & #hepatology Reviews and opinion www.nature.com/nrgastro #GastroEdPick selections by the Editors: Katrina (@heykatray.bsky.social), Jordan & Eleni #Gastrosky #LiverSky #Microsky #Medsky

PostsRepliesMedia
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 24/09/2026
Our OCTOBER ISSUE is live! Nutrient absorption & the small intestine, cytoskeleton and fibrogenesis, synthetic data in gastrointestinal medicine, cell therapies in IBD, and much more! www.nature.com/nrgastro/vol...
COVER: Regional organization of the small intestine, inspired by the Review starting on p741.
010 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/08/2026
Our SEPTEMBER ISSUE is live! Pancreatic development, γδ T cells in CRC and liver cancer, precision nutrition in IBD, SLD in Latin America, and much more! www.nature.com/nrgastro/vol...
COVER: Pancreatic development, inspired by the Review starting on p674.
051 5
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 03/08/2026
Our AUGUST ISSUE is live! Gut-brain axis, portal hypertension and HCC in cirrhosis, autoimmune gastritis, cytochrome P450 oxidoreductase in MASLD, and much more! www.nature.com/nrgastro/vol...
COVER: Gut–brain signalling, inspired by the Review starting on p608.
000 0
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 30/06/2026
Our JULY ISSUE is live! Microplastics and the liver, SLD prevention and management, colitis-associated CRC, microbiome and host metabolic health, and much more! www.nature.com/nrgastro/vol...
COVER: Microplastics, nanoplastics and the liver, inspired by the Perspective starting on p585.
131 3
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 02/06/2026
Our JUNE ISSUE is live! Therapeutic targets for MASH, metabotherapy for intestinal disease, germiline mutations and somatic mosaicism in SLD-related liver cancer, artificial intelligence in IBD, and much more! www.nature.com/nrgastro/vol...
COVER: Putting steatotic liver disease on a global stage, inspired by the Comment starting on p449.
072 7
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 30/04/2026
Our MAY ISSUE is live! Consensus statement on gut health, dietary proteins and colonic disease, cholesterol metabolism, acute-on-chronic liver failure, and much more! www.nature.com/nrgastro/vol...
COVER: Defining gut health, inspired by the Consensus Statement starting on p432.
051 5
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 31/03/2026
Our APRIL ISSUE is live! Preclinical models in MASLD-HCC, mucosal glycans and IBD, necrosis in liver inflammation and cancer, public health policies for SLD screening, and much more! www.nature.com/nrgastro/vol...
Models of MASLD and MASLD-HCC, inspired by the Review starting on p286.
000 0
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 02/03/2026
Our MARCH ISSUE is live! Surgery in HCC, abdominal pain in IBD, WNT–β-catenin signalling in HCC, liver disease and HIV infection, and much more! www.nature.com/nrgastro/vol...
COVER: Improving surgery for liver cancer, inspired by the Review starting on p208.
131 3
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 02/02/2026
FEBRUARY ISSUE | YEAR IN REVIEW: Gastric cancer in 2025 "Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets" www.nature.com/articles/s41... #Oncsky
Current breakthroughs include perioperative immunotherapy, HER2-directed therapy sequencing and a decisive shift towards biomarker-driven treatment.
000 0
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 02/02/2026
FEBRUARY ISSUE | YEAR IN REVIEW: Viral hepatitis in 2025 "Novel insights into chronic HBV infection" www.nature.com/articles/s41... #Hepsky #Liversky
Fig. 1: Diagram illustrating the risk of hepatocellular carcinoma attributable to chronic hepatitis B infection and strategies to mitigate it.
110 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 02/02/2026
FEBRUARY ISSUE | YEAR IN REVIEW: IBD in 2025 "The 3 Ps of IBD today — prevention, pre-diagnosis and participation" www.nature.com/articles/s41... #Gastrosky
Fig. 1: Trends in IBD care 2025: from prevention to early intervention.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 02/02/2026
FEBRUARY ISSUE | YEAR IN REVIEW: Pancreatic cancer in 2025 "Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms" www.nature.com/articles/s41... #Oncsky
" long-term data on personalized neoantigen vaccine approaches in resected pancreatic adenocarcinoma, detailed clinico-genomic analyses of large clinical trial datasets, and therapeutic strategies for early-stage disease"
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 02/02/2026
FEBRUARY ISSUE | YEAR IN REVIEW: MASLD in 2025 "Heart–liver co-management in MASLD: from concept to clinical practice" www.nature.com/articles/s41... #Liversky
Fig. 1: Key milestones in heart–liver co-management of MASLD.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 02/02/2026
FEBRUARY ISSUE | YEAR IN REVIEW: Gut microbiota in 2025 "Pushing the frontier of gut microbiome health cross-kingdom and cross-organ" www.nature.com/articles/s41... #Microsky
Fig. 1: Roles of the gut multi-kingdom microbiome in regulating the homeostasis and disease susceptibility of intestinal and extraintestinal organs.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 02/02/2026
Our February ISSUE is live! Year in Review 2025, gut virome, gut-brain axis, liver-brain axis, cancer registries in Africa, and much more! www.nature.com/nrgastro/vol...
Looking back on 2025, inspired by the Year in Reviews starting on p112.
243 4
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE | Our Featured ROADMAP is on "Towards a reference cell atlas of liver diversity over the human lifespan" www.nature.com/articles/s41... #Liversky
Fig. 2: Methods for single-cell analyses to build an atlas for healthy human liver cells.
020 2
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE | REVIEW "Proteases in intestinal health and disease" www.nature.com/articles/s41... #Gastrosky
Fig. 3: Role of proteases in gut physiology.
130 3
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE | CONSENSUS STATEMENT "Cholangiocarcinoma 2026: status quo, unmet needs and priorities" www.nature.com/articles/s41... #Liversky #Oncsky
Fig. 2: Cholangiocarcinoma mortality worldwide.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE | REVIEW "Advances in liver and pancreas organoids: how far we have come and where we go next" www.nature.com/articles/s41... #Liversky #Gastrosky
Fig. 2: Pancreas organoids derived from different tissue-resident cells.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE | REVIEW "IL-1 family of cytokines in gastrointestinal and liver disorders" www.nature.com/articles/s41... #Gastrosky #Liversky
Fig. 1: IL-1 family members have a pivotal role in inflammation of the gastrointestinal tract.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE | NEWS & VIEWS "Rethinking B cells in ulcerative colitis: a CAR T cell opportunity" www.nature.com/articles/s41... #Gastrosky
Fig. 1: Mechanistic rationale and process of CD19 CAR T cell therapy in ulcerative colitis.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE | RESEARCH HIGHLIGHT "GWAS on idiopathic achalasia" www.nature.com/articles/s41... #Gastrosky
RESEARCH HIGHLIGHT "GWAS on idiopathic achalasia"
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE | RESEARCH HIGHLIGHT "Fibroblast spatial heterogeneity in Crohn’s disease fistulae" www.nature.com/articles/s41... #Gastrosky
 RESEARCH HIGHLIGHT "Fibroblast spatial heterogeneity in Crohn’s disease fistulae"
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE | RESEARCH HIGHLIGHT "Optimizing sacral nerve stimulation to relieve chronic constipation" www.nature.com/articles/s41... #Gastrosky
RESEARCH HIGHLIGHT "Optimizing sacral nerve stimulation to relieve chronic constipation"
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE | RESEARCH HIGHLIGHT "SOLSTICE: tobevibart plus elebsiran for hepatitis D" www.nature.com/articles/s41... #Hepsky #IDsky #Liversky
RESEARCH HIGHLIGHT "SOLSTICE: tobevibart plus elebsiran for hepatitis D"
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
JANUARY ISSUE |COMMENT "The future of treating pancreatic exocrine insufficiency" www.nature.com/articles/s41... #Gastrosky
Table 1 Non-animal pancreatic enzyme preparations
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 05/01/2026
Our JANUARY ISSUE is live! Proteases and the gut, IL-1 cytokines, liver and pancreas organoids, cholangiocarcinoma, liver cell atlas and much more! www.nature.com/nrgastro/vol...
COVER: Liver cell atlas, inspired by the Roadmap on p97.
161 6
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 19/12/2025
It is time for a well-deserved break for the Editorial team over the holidays - the editorial office will be closed from now until 5th January 🎄🎁☃️ Thanks to all our authors, referees and readers, it's been a fantastic year. Check out our wonderful covers! www.nature.com/nrgastro/vol... #gastrosky
All the monthly covers from Nature Reviews Gastroenterology & Hepatology in 2025
030 3
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 08/12/2025
REVIEW | Global burden of #hepatitisB virus: current status, missed opportunities and a call for action www.nature.com/articles/s41... Full-text link: rdcu.be/eTFsa This figure shows the care cascade of HBV infection and current gaps #HBV #NoHep #hepatitis #Liversky
Fig. 2: The care cascade of HBV infection and the current gaps
165 6
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE | REVIEW "Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease" www.nature.com/articles/s41... #Liversky
Fig. 1: Areas for improving the definition of metabolic and alcohol-related liver disease (MetALD) for clinical trials.
011 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE | REVIEW "Interaction of inflammation and portal hypertension in cirrhosis progression" www.nature.com/articles/s41... #Liversky
Fig. 2: Organ-level consequences of portal hypertension (PH) and inflammation in cirrhosis.
120 2
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE | REVIEW "Multifaceted effects of the microbiome in pancreatic cancer: from association to modulation" www.nature.com/articles/s41... #Gastrosky #Microsky
Fig. 1: Role of microbiome modulation of immune function in pancreatic ductal adenocarcinoma (PDAC).
122 2
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE | Our Featured REVIEW is on "Tissue-resident memory CD8+ T cells: master deciphers of the hepatic environment" www.nature.com/articles/s41... #Liversky
Fig. 3: Environmental cues modulating CD8+ tissue-resident memory T (TRM) cell phenotype and function.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE |NEWS & VIEWS "A neurobiotic sense curbs feeding: a new frontier in gut–brain communication" www.nature.com/articles/s41... #Gastrosky
Fig. 1: Neurobiotic sense of feeding control.
111 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE | RESEARCH HIGHLIGHT "Pharmacological management of obesity" www.nature.com/articles/s41... #Medsky
Research highlights:
- UEG Week 2025
- Predicting mortality in cirrhosis
- Metastasis and pericytes in oesophageal cancer
- Pharmacological management of obesity
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE | RESEARCH HIGHLIGHT "Metastasis and pericytes in oesophageal cancer" www.nature.com/articles/s41... #Gastrosky
Research highlights:
- UEG Week 2025
- Predicting mortality in cirrhosis
- Metastasis and pericytes in oesophageal cancer
- Pharmacological management of obesity
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE | RESEARCH HIGHLIGHT "Predicting mortality in cirrhosis" www.nature.com/articles/s41... #Liversky
Research highlights:
- UEG Week 2025
- Predicting mortality in cirrhosis
- Metastasis and pericytes in oesophageal cancer
- Pharmacological management of obesity
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE | RESEARCH HIGHLIGHT "UEG Week 2025" www.nature.com/articles/s41... #Gastrosky #Liversky
Research highlights:
- UEG Week 2025
- Predicting mortality in cirrhosis
- Metastasis and pericytes in oesophageal cancer
- Pharmacological management of obesity
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE |COMMENT "Submucosal electronics for long-term in situ diagnosis and therapeutics of gastrointestinal diseases" www.nature.com/articles/s41... #Gastrosky
Fig. 1: Submucosal electronics and their advantages in the gastrointestinal tract.
110 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
DECEMBER ISSUE |COMMENT "Bezafibrate for primary biliary cholangitis: time to act on the evidence" www.nature.com/articles/s41... #Gastrosky
Fig. 1: Evidence for bezafibrate in second-line primary biliary cholangitis (PBC) treatment and the crucial questions it raises.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 25/11/2025
Our DECEMBER ISSUE is live! Hepatic T cells, microbiome and pancreatic cancer, portal hypertension and cirrhosis, metabolic and alcohol-related liver disease and much more! www.nature.com/nrgastro/vol...
COVER: ‘Jekyll and Hyde’ roles of memory T cells in the liver, inspired by the Review on p814.
2115 11
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 27/10/2025
NOVEMBER ISSUE | Our Featured PERSPECTIVE is on "Credible inferences in microbiome research: ensuring rigour, reproducibility and relevance in the era of AI" www.nature.com/articles/s41... #Gastrosky #Microsky
Fig. 2: AI-integrated cycle of microbiome research, from hypothesis generation to therapeutic implementation.
031 3
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 27/10/2025
NOVEMBER ISSUE | PERSPECTIVE "Large language models for clinical decision support in gastroenterology and hepatology" www.nature.com/articles/s41... #Gastrosky #Liversky
Fig. 2: Stages of clinical decision making and opportunities for LLM-based decision support.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 27/10/2025
NOVEMBER ISSUE | REVIEW "Parental diet and offspring health: a role for the gut microbiome via epigenetics" www.nature.com/articles/s41... #Gastrosky #Microsky
Fig. 3: Epigenetic effects of maternal dietary intake.
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 27/10/2025
NOVEMBER ISSUE | REVIEW "Defining the mucosal ecosystem: epithelial–mesenchymal interdependence in gastrointestinal health and disease" www.nature.com/articles/s41... #Gastrosky
Fig. 2: Epithelial–stromal remodelling during intestinal regeneration.
110 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 27/10/2025
NOVEMBER ISSUE |JOURNAL CLUB "Diagnosing paediatric coeliac disease" www.nature.com/articles/s41... #Gastrosky
"The strength of the AbCD study lies in its rigorous prospective design and multicentre enrolment"
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 27/10/2025
NOVEMBER ISSUE | RESEARCH HIGHLIGHT "Aspirin and recurrence of PI3K-mutated CRC" www.nature.com/articles/s41... #Gastrosky #Oncsky
Research Highlights: 
NeuroGASTRO 2025
Maternal gut microbiome in early pregnancy: predictor of preterm birth?
Nivolumab and ipilimumab as neoadjuvant therapy for potentially resectable HCC
Aspirin and recurrence of PI3K-mutated CRC
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 27/10/2025
NOVEMBER ISSUE | RESEARCH HIGHLIGHT "Nivolumab and ipilimumab as neoadjuvant therapy for potentially resectable HCC" www.nature.com/articles/s41... #Liversky #Oncsky
Research Highlights: 
NeuroGASTRO 2025
Maternal gut microbiome in early pregnancy: predictor of preterm birth?
Nivolumab and ipilimumab as neoadjuvant therapy for potentially resectable HCC
Aspirin and recurrence of PI3K-mutated CRC
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 27/10/2025
NOVEMBER ISSUE | RESEARCH HIGHLIGHT "Maternal gut microbiome in early pregnancy: predictor of preterm birth?" www.nature.com/articles/s41... #Gastrosky #Microsky
Research Highlights: 
NeuroGASTRO 2025
Maternal gut microbiome in early pregnancy: predictor of preterm birth?
Nivolumab and ipilimumab as neoadjuvant therapy for potentially resectable HCC
Aspirin and recurrence of PI3K-mutated CRC
100 1
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 27/10/2025
NOVEMBER ISSUE | RESEARCH HIGHLIGHT "NeuroGASTRO 2025" www.nature.com/articles/s41... #Gastrosky
Research Highlights: 
NeuroGASTRO 2025
Maternal gut microbiome in early pregnancy: predictor of preterm birth?
Nivolumab and ipilimumab as neoadjuvant therapy for potentially resectable HCC
Aspirin and recurrence of PI3K-mutated CRC
100 1